Fundraising Fox

ArchiMed Pte. Ltd.Full Portfolio

11 tracked investments · listed companies and verified rows first

Cevaceva.comin𝕏NASDAQ: CEVA✓ verified

Ceva is a global animal health company specializing in vaccines, reproductive management products, and behavioral control solutions for livestock and companion animals.

AgTechBiotechHealthtechLibourne, FR

Amir Panush(Chief Executive Officer and Director)Dr Marc Prikazsky(CEO)

Co-investorsMérieux Equity PartnersContinental Grain CompanyEMZ PartnersMitsui & CoSagardTemasek+1 more

Arkstonearkstone.aiin✓ verified

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Dave Gross(Co-Founder, Chief Technology Officer)inDr. Ari Frenkel(Co-Founder, Chief Science Officer)Sol Levi(Co-Founder, Chief Customer Officer)inIan Campbell(CEO and Executive Chairman)in

Co-investorsARCHIMED Japan

Cardiolinecardioline.cominDec 2021

Cardioline develops diagnostic cardiology and telemedicine solutions, including ECG devices and telecardiology tools, for healthcare providers and clinicians.

Digital HealthHealthtechMedical Devices

Co-investorsARCHIMED Japan

Corealiscorealispharma.cominMay 2022

Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies.

Advanced ManufacturingBiotechHealthtechMedical DevicesLaval, CA

David Leroux-Petersen(Chief Executive Officer)inPatrick Gosselin(Vice-President, Pharmaceutical R&D)Yves Mouget(Vice-President, Analytics)Pascal Tougas(Chief Financial Officer)in

Co-investorsARCHIMED JapanLa Caisse

Insteminstem.comin

Instem provides SaaS platforms and services for research and development in the life sciences industry, serving pharmaceutical companies, CROs, CDMOs, academic research institutions, biotechnology firms, industrial organizations, and agrichemical companies.

BiotechDigital HealthEnterprise SoftwareSaaSUnited Kingdom, GB

Co-investorsARCHIMED Japan

Natus Sensorynatussensory.comin

Natus Sensory develops medical devices and solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems.

Digital HealthHardwareHealthtechMedical Devices

Peter(Chief Executive Officer)

BoardMatthias(Executive Chairman of the Board)

Co-investorsARCHIMED Japan

Polypluspolyplus-sartorius.comin

Polyplus (a Sartorius company) develops FectoVIR-LV, an animal-component-free transfection reagent for producing lentiviral vectors in suspension HEK-293 cells at large manufacturing scale.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices

Co-investorsARCHIMED JapanWarburg Pincus

Renata Medicalrenatamedical.cominAug 2026 · $25M

Renata Medical develops and commercializes medical devices for unmet pediatric needs, with a focus on transcatheter implants and delivery systems such as stents for treating congenital heart defects in newborns and children.

BiotechHardwareHealthtechMedical DevicesCosta Mesa, US

Dr. Zahn(Chief Medical Officer)Dustin Armer(Founder)inEASON ABBOTT(Co-founder & COO)

Stagostago.comin

Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsARCHIMED JapanLa Caisse

Suanfarmasuanfarma.comin𝕏

Suanfarma develops, manufactures, and distributes active pharmaceutical ingredients (APIs) for the global pharmaceutical industry, serving over 400 customers across 70+ countries.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtech

Co-investorsARCHIMED Japan

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Pyxant Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.